Government officials have directed NeuroXPF – a marketer of CBD founded by a former NFL lineman – to email an FDA COVID-19 task force, explaining steps it has taken to correct alleged violations of law tied to marketing claims.
Federal regulators have targeted a company founded by a former professional football player for making claims that CBD can treat COVID-19, the deadly respiratory disease with over 200,000 cases in the United States as of early April 2020.
“The FDA has determined that your website offers cannabidiol (CBD) products for sale in the United States and that these products are intended to mitigate, prevent, treat, diagnose or cure COVID-19,” government officials wrote in a March 31 warning letter to Las Vegas-based NeuroXPF.
FDA determined the products are unapproved new and misbranded drugs sold in violation of the Federal Food, Drug & Cosmetic Act.
“We want everyone to take CBD and take advantage of its potential to help prepare your body to fight a coronavirus infection,” NeuroXPF stated on its website, per the government’s warning letter.
Read the full article on Natural Products Insider